$XBI $115.04 +5.0%%
Covid Updates
$
Pipeline Updates
$LEGN +9.8% Legend Biotech to Host Hybrid KOL Event Detailing CARTITUDE Data from the 63rd American Society of Hematology (ASH) Annual Meeting source
$FBIO +7.6% Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease source
$VACC +3.1% Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV source
$RCKT +8.5% Rocket Pharmaceuticals to Host In-Person Investor and Analyst Event and Webcast on Tuesday, Dec. 14 at 7:30 a.m. ET to Discuss Updated Clinical Data Presented at the 63rd American Society of Hematology (ASH) Annual Meeting source
$MGTX +17.8% MeiraGTx Announces Positive Preliminary Data from the AQUAx Phase 1 Clinical Trial of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia source
$CLNN -4.1% Clene Nanomedicine’s RESCUE-ALS Phase 2 Results Selected for Late-Breaking Presentation at 32nd International Symposium on ALS/MND source
$IDYA +7.6% IDEAYA Reports Clinical Data from Phase 2 Expansion Dose of Darovasertib and Crizotinib Synthetic Lethal Combination in Heavily Pre-Treated Metastatic Uveal Melanoma source
Business Updates
$PCRX +5.0% PACIRA BIOSCIENCES REPORTS PRELIMINARY NET PRODUCT SALES FOR EXPAREL® AND IOVERA° OF $48.0 MILLION FOR NOVEMBER 2021 source
Posted by JM
Comments